AZT-induced mitochondrial myopathy

Ital J Neurol Sci. 1992 Dec;13(9):723-8. doi: 10.1007/BF02229156.

Abstract

Histochemical, electron microscopy and biochemical studies were performed on muscle biopsy specimens from 11 AIDS patients treated with zidovudine. A peculiar association of structural abnormalities and mitochondrial dysfunction was found. Focal cytochrome c oxidase (COX) deficiency was evident in muscle sections from 9 patients, 8 of whom had received long-term treatment while one had been treated for 1 month only. Electron microscopy showed changes in number, size and structure of mitochondria. Biochemical studies proved partial COX and succinate cytochrome c reductase (SCR) deficiency in 4 patients; one patient had only reduced SCR activity. Our data confirm that AZT therapy can cause toxic myopathy with mitochondrial dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Electron Transport Complex IV / metabolism
  • Female
  • Humans
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Mitochondria, Muscle / enzymology*
  • Mitochondria, Muscle / ultrastructure
  • Mitochondrial Myopathies / chemically induced*
  • Mitochondrial Myopathies / enzymology
  • Muscles / enzymology
  • Muscles / ultrastructure
  • Succinate Cytochrome c Oxidoreductase / metabolism
  • Zidovudine / adverse effects*

Substances

  • Zidovudine
  • Succinate Cytochrome c Oxidoreductase
  • Electron Transport Complex IV